Results for aspirate translation from English to Maltese

distal protected aspirate
aspirat distali protett

regurgitation, increase in stomach aspirate
rigurġitazzjoni, żjieda fl-aspirazzjoni mill-istonku

aspirate reconstituted vaccine back into syringe.
iġbed lura l - vaċċin rikostitwit ġewwa s- siringa.

aspirate the reconstituted vaccine back into the syringe.
iġbed lura l - vaċċin rikostitwit ġewwa s- siringa.

regurgitation, increased gastric aspirate, necrotising enterocolitis
regurġitazzjoni, gastric aspirate miżjud, enterokolite nekrotika

open the valve and aspirate a suitable quantity of liquid.
iftaħt il-valv u aspira kwantita` xierqa ta' likwidu.

if needed, inject back into vial and aspirate again to expel air.
injetta lura għal ġol- kunjett u erġa 'iġbed biex tkeċċi l- arja, jekk meħtieġ.

check if cytopaenia is related to leukaemia (marrow aspirate or biopsy).
iċċekkja jekk iċ-ċitopenja hiex relatata mal-lewkimja (aspirate tal-mudullun jew bijopsija).

check whether cytopenia is related to leukaemia (marrow aspirate or biopsy).
ara jekk iċ-ċitopenja hiex relatata mal- lewkimja (permezz ta’ aspirat mill- mudullun jew bijospija).

aspirate for several seconds to ensure no blood appears after insertion of the needle into the muscle.
iġbed għal diversi sekondi biex tiżgura li ma jidher l- ebda demm wara li tidħol il- labra fil- muskolu.

holding the syringe barrels with one hand, aspirate both syringes slowly (vials facing up).
billi żżomm it- tubu taċ- ċilindru tas - siringa b' id waħda, iġbed iż- żewġ siringi bil- mod (kunjetti jħarsu 'l fuq).

if the anc does not recover by 6 weeks from the start of a treatment cycle, a bone marrow aspirate / biopsy should be performed to determine possible refractory disease.
jekk l- anc ma jirkuprax sa 6 ġimgħat mill- bidu taċ- ċiklu ta 'trattament, aspirat/ biopsija tal- mudullun ta' l- għadma għandha ssir biex jiġi determinat jekk hemmx xi marda refrattarja.

a bone marrow aspirate and biopsy should normally have been done over the course of the disease and treatment, particularly in patients over 60 years of age, for those with systemic symptoms or abnormal signs such as increased peripheral blast cells.
normalment għandhom isiru aspirazzjoni u bijopsija tal-mudullun matul il-kors tal-marda u tal-kura, speċjalment f’pazjenti b’età ’l fuq minn 60 sena, u għal dawk b’sintomi sistemiċi jew sinjali mhux normali bħal żjieda fiċ-ċelluli blast periferali.

consideration should be given to performing a bone marrow aspirate and biopsy over the course of the disease and treatment, particularly in patients over 60 years of age, those with systemic symptoms, or abnormal signs such as increased peripheral blast cells.
għandha tiġi kkunsidrata li ssir aspirazzjoni u bijopsija mill-mudullun tal-għadam matul il-marda u l-kura, speċjalment f’pazjenti b’età ’l fuq minn 60 sena, dawk b’sintomi sistemiċi jew b’sinjali mhux normali bħal żjieda fiċ-ċelluli blastiċi periferali.

in the single-arm, open-label trial in saa, patients had bone marrow aspirates evaluated for cytogenetic abnormalities.
waqt il-prova fost grupp wieħed ta’ pazjenti b’saa, il-pazjenti ttiħdilhom kampjun mill-mudullun biex issir evalwazzjoni ta’ anormalitajiet ċitoġenetiċi.